A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation
Open Access
- 1 November 2003
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 18 (11) , 2315-2318
Abstract
BACKGROUND: A combination of mifepristone and misoprostol provides an effective method of medical abortion for early pregnancy. This is the first randomized trial comparing the use of sublingual misoprostol with vaginal misoprostol in combination with mifepristone for termination of early pregnancies up to 63 days. METHODS: A total of 224 women who requested legal termination of pregnancy up to 63 days were randomized by computer‐ generated list into two groups and given 200 mg of oral mifepristone followed 48 h later by either 800 µg of sublingual (n = 112) or vaginal (n = 112) misoprostol. RESULTS: Complete abortion occurred in 98.2% (95% CI: 93–99) of women in the sublingual group and 93.8% (95% CI: 88–97) in the vaginal group. There were three ongoing pregnancies in the vaginal group but none in the sublingual group. The median duration of vaginal bleeding was 17 days. There was no serious complication. Fever, chills and gastrointestinal side‐effects (nausea, vomiting and diarrhoea) were significantly more common in the sublingual group. CONCLUSIONS: The combination of mifepristone and misoprostol is effective for medical abortion up to 63 days. Both the sublingual and vaginal are effective routes of administration. Further randomized trials are required to find out the optimal dose of sublingual misoprostol that can give the highest complete abortion rate and lowest incidence of side‐effects.Keywords
This publication has 11 references indexed in Scilit:
- A prospective randomized study on the measured blood loss in medical termination of early pregnancy by three different misoprostol regimens after pretreatment with mifepristoneHuman Reproduction, 2002
- Pharmacokinetics of different routes of administration of misoprostolHuman Reproduction, 2002
- The effect of contraceptive pills on the measured blood loss in medical termination of pregnancy by mifepristone and misoprostol: a randomized placebo controlled trialHuman Reproduction, 2002
- A comparative study of surgical and medical procedures: 932 pregnancy terminations up to 63 days gestationHuman Reproduction, 2001
- Does an acidic medium enhance the efficacy of vaginal misoprostol for pre-abortion cervical priming?Human Reproduction, 1999
- An effective regimen for early medical abortion: a report of 2000 consecutive casesHuman Reproduction, 1998
- Vaginal misoprostol compared with oral misoprostol in termination of second-trimester pregnancyObstetrics & Gynecology, 1997
- Absorption kinetics of misoprostol with oral or vaginal administrationObstetrics & Gynecology, 1997
- Endocrinology: Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortionHuman Reproduction, 1995
- Induction of Abortion with Mifepristone (RU 486) and Oral or Vaginal MisoprostolNew England Journal of Medicine, 1995